Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: Primary Endpoint Analysis from the SUNSHINE and SUNRISE Phase III Trials
暂无分享,去创建一个
A. Gottlieb | L. Uhlmann | G. Jemec | D. Keefe | M. Woźniak | Elisa Muscianisi | A. Alavi | R. Martin | H. Boreham | Xiaoling Wei | Angela Llobet Martinez | Li Chen